top of page

Narcan approval could be a game changer — if people can afford it

WVDII

Dr. Susan Bissett of the Drug Intervention Institute weighs in on Narcan's over the counter availability.


The Food and Drug Administration’s move to make a version of naloxone available without a prescription marks a major milestone in the fight against opioid addiction, and anti-addiction advocates hope it will break down barriers and help expand access to the drug.


The agency approved Narcan, the brand-name nasal spray manufactured by Emergent BioSolutions. But the company did not say how much it will charge, and there is concern that unless it is priced affordably, over-the-counter Narcan will likely have little impact on the people who need it most.


 
 

Comments


ABOUT WVDII

West Virginia Drug Intervention Institute, Inc. is an independent 501(C)(3) entity with a primary mission to reduce opioid and drug-related deaths by (a) preventing substance use through education, (b) reducing overdose deaths through naloxone distribution and training, and (c) supporting harm reduction and other drug-response efforts. 

DII_2023_white.png

FOLLOW

  • Facebook
  • Twitter
  • Instagram
  • YouTube

CONTACT

West Virginia Drug Intervention Institute, Inc.

118 Capitol Street

Charleston, WV 25301

 

Phone: (681) 205-2287

Email: susan@wvdii.org

truist-logo-white.png

© 2020 by West Virginia Drug Intervention Institute, Inc.

bottom of page